Table 1.
Characteristics | Young | Middle-aged | P value |
---|---|---|---|
(n = 198) | (n = 1096) | ||
Gender | <0.001 | ||
male | 115 (58.1) | 895 (81.7) | |
female | 83 (41.9) | 201 (18.3) | |
Comorbidity | <0.001 | ||
Negative | 189 (95.5) | 829 (75.6) | |
Positive | 9 (4.5) | 267 (24.4) | |
Hypertension | 0 (0.0) | 153 (14.0) | <0.001 |
Coronary heart disease | 0 (0.0) | 22 (2.0) | 0.064 |
Diabetes mellitus | 2 (1.0) | 53 (4.8) | 0.014 |
COPDa | 0 (0.0) | 7 (0.6) | 0.389 |
Brain infarction | 0 (0.0) | 18 (1.6) | 0.094 |
Chronic hepatitis B | 6 (3.0) | 12 (1.1) | 0.044 |
Tumor location | <0.001 | ||
Upper | 15 (7.6) | 396 (36.1) | |
Middle | 58 (29.3) | 242 (22.1) | |
Lower | 123 (62.1) | 444 (40.5) | |
whole | 2 (1.0) | 14 (1.3) | |
Tumor size | 0.012 | ||
< 5 cm | 117 (59.1) | 541 (49.4) | |
≥ 5 cm | 81 (40.9) | 555 (50.6) | |
Histologic type | <0.001 | ||
Well differentiated | 7 (3.5) | 123 (11.2) | |
Moderately differentiated | 17 (8.6) | 323 (29.5) | |
Poorly differentiated | 164 (82.8) | 587 (53.6) | |
Signet ring cell or mucinous | 10 (5.1) | 63 (5.7) | |
T status | 0.012 | ||
T1 | 51 (25.8) | 192 (17.5) | |
T2 | 31 (15.7) | 168 (15.3) | |
T3 | 72 (36.4) | 390 (35.6) | |
T4 | 44 (22.2) | 346( 31.6) | |
N status | 0.067 | ||
N0 | 62 (31.3) | 392 (35.8) | |
N1 | 27 (13.6) | 205 (18.7) | |
N2 | 41 (20.7) | 206 (18.8) | |
N3 | 68 (34.3) | 293 (26.7) | |
Tumor marker | |||
CEA | <0.001 | ||
Positive | 16 (8.1) | 245(22.4) | |
Negative | 182 (91.9) | 851 (77.6) | |
AFP | 0.007 | ||
Positive | 3 (1.5) | 69 (6.3) | |
Negative | 195 (98.5) | 1027 (93.7) | |
CA19-9 | 0.020 | ||
Positive | 26 (13.1) | 221 (20.2) | |
Negative | 172 (86.9) | 875 (79.8) | |
CA125 | 0.152 | ||
Positive | 14 (7.1) | 51 (4.7) | |
Negative | 184 (92.9) | 1045 (95.3) |
a COPD: chronic obstructive pulmonary disease